Avricore Health Inc

Home
Avricore Health Inc

We are committed to becoming a health innovator and applying technologies at the forefront of science. Vanc Pharmaceuticals Inc.

(Vancpharm) is a Canadian pharmaceutical company focused on generic drugs and over-the-counter health products. Current brands produced by Vanc Pharmaceuticals Inc. are CortiVera (anti-itch cream), CortiVera Plus (anti-itch cream), and Hema-Fer (iron supplement).

22/07/2025

HealthTab is fast and convenient—get your results STAT. With lab-quality analysis and easy-to-understand results ready in an instant, we're helping pharmacists deliver quicker insights, earlier interventions, and improved care right in the community.

Learn more about HealthTab: https://www.healthtab.com/

14/07/2025

The UK government has published its 2025 Spending Review, outlining priorities under its Plan for Change. This includes three key shifts in the healthcare system to move it from analogue to digital, treatment to prevention, and hospital to community. More highlights include:

→ A £2.3B real-terms increase in health capital budget from 2023-24 to 2029–30 for a >20% increase—the largest in NHS history.

→ Up to £10B for NHS digital transformation by 2028–29 for nearly a 50% increase from 2025–26.

→ Expanded investment in proactive care and primary services with a focus on improving efficiency and long-term sustainability.

At Avricore, we know that pharmacists are key to this future. HealthTab is already helping pharmacists deliver accessible, preventative care—exactly the kind of innovation this plan envisions.

Read more: https://bit.ly/3ZYz7l5

12/07/2025

We're pleased to announce the expansion of HealthTab™ into pharmacies in North Central London—making it the second NHS Integrated Care Board (ICB), after North East London, to join this groundbreaking initiative aimed at tackling health inequalities through cholesterol screening.

Our team is proud to be working alongside a group of visionary healthcare partners to lead innovation in pharmacy care. The momentum behind this initiative continues to grow, and we’re excited to see HealthTab™ expanding its impact across the UK.

Read more: https://bit.ly/4nCUDpH

12/06/2025

The number aged 60 and over waiting more than 12 hours to be transferred, admitted or discharged increased to 1.15 million in 2024, up from 991,068 in 2023. The figure was 305,619 in 2019.

These delays reflect a broader strain on the system—and a clear signal that reactive care is no longer sustainable.

By shifting focus to early detection and bringing screening into the community, pressure on hospitals can be eased while long-term outcomes are improved. With the NHS prioritizing this transformation, HealthTab is helping make it happen.

Read more: https://bit.ly/3FjjP30

05/06/2025

We’re pleased to announce the appointment of Rodger Seccombe as Avricore’s new CEO. As our Chief Technology Officer and President & Co-Founder of HealthTab, Rodger has played a pivotal role in developing our flagship platform and its implementation in communities both locally and internationally.

We extend our sincere thanks to Hector Bremner for his many contributions as CEO, including major milestones such as recognition in the TSX Venture 50 and Deloitte's Technology Fast 50 Companies-to-Watch.

We wish Mr. Bremner all the best in his next chapter as we welcome Mr. Seccombe, whose leadership comes at an exciting time as we continue expanding in the UK.

Read more: https://bit.ly/3FA19fF

04/06/2025

As NHS plans for POCT continue to evolve through the year, the momentum behind HealthTab also continues to grow. This aligns with the scheduled 2026 mandate for pharmacists to prescribe for chronic conditions like heart disease and diabetes, positioning Avricore in a spot to lead.

We’re confident in our growth trajectory, being particularly encouraged by recent NHS pharmacy budget commitments that reaffirm the sector’s strategic role in primary care and chronic disease management.

Read more: https://bit.ly/3YWo5vS

04/06/2025

“Every day, we’re proving just how valuable HealthTab™ can be in the hands of pharmacists.”

In our latest corporate update, we’re proud to share about HealthTab’s steady momentum as the many pieces of UK expansion come together. With our eyes set on thoughtful progress, the empowering impact that we can see today gives us confidence in what’s to come down the pipeline as we continue our focus on our expansion plan.

Read more: https://bit.ly/3FweYf5

27/05/2025

Do you know where your biomarker values sit? HealthTab makes it quick, easy, and more accessible than ever for patients to interpret their health data.

By bringing convenient screening to the community level, we're empowering patients to proactively take charge of their health—targeting the chronic disease crisis early, where intervention has the greatest impact on healthcare systems.

Learn more about HealthTab: https://www.healthtab.com/

15/05/2025

How is market potential looking? With the global point-of-care testing market projected to nearly triple from 2021 to 2030, demand has been accelerating for fast, accurate health data where it matters most: in the community. It's clear that POCT has welcomed a new era.

Avricore is well-positioned at the front of this growth, delivering real-time, lab-accurate results in the community pharmacy through HealthTab.

As healthcare shifts towards proactive care, the opportunity in POCT only grows.

Read more: https://bit.ly/3S6A8Tw

02/05/2025

In our latest corporate update: 2024 was a record year for Avricore + with UK expansion on track, HealthTab is proving its value in bringing proactive, pharmacy-based care to the forefront.

Looking ahead, our focus is on growing HealthTab’s UK footprint, with a two-phase roadmap to expand beyond North East London and to prepare for national scaling with the NHS.

Backed by early proven success and growing support for pharmacy-based POCT in chronic disease management, we’re building momentum through 2025 and beyond.

Read more: https://bit.ly/3YWo5vS

24/04/2025

An NHS report reveals that out of several types of interventions for cardiovascular disease (CVD), community pharmacies aiding in detection delivered the greatest ROI—£7.52 per £1 invested over five years—and also the quickest return, within just one year.

The resulting cost savings of community pharmacies playing a larger role in early detection are immense, and innovative pharmacy solutions like HealthTab are set to help close the gaps between accessible care, improved health outcomes, and economic sustainability.

Read more: https://bit.ly/4hMCRMu

14/04/2025

In this year's Global Health Care Outlook from Deloitte, the acceleration of digital transformation across healthcare organizations is top priority for health systems around the world.

As a pharmacy services innovator bringing turnkey digital solutions to the community, we're sitting at the forefront of this transformation and are making the future of accessible, data-driven healthcare a present reality. With our continued commitment to collaborating closely with our partners across the sector, we're excited to keep expanding our impact through the months to come.

Read more: https://bit.ly/4l2IIA8

Address

Telephone

+16042472639

Website

http://www.avricorehealth.com/

Alerts

Be the first to know and let us send you an email when Avricore Health Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Avricore Health Inc:

Shortcuts

Address
Telephone
Alerts
Contact The Practice
Claim ownership or report listing
Want your practice to be the top-listed Clinic?

Country:

City: